Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.
AB Sciex

Elevated Blood Eosinophil Levels Predict Asthma Exacerbations

By Labmedica International staff writers
Posted on 05 Jun 2014
Image: Blood film showing five active eosinophils with a multisegmented nucleus and numerous eosinophilic granules (Photo courtesy of American Academy of Pediatrics).
Image: Blood film showing five active eosinophils with a multisegmented nucleus and numerous eosinophilic granules (Photo courtesy of American Academy of Pediatrics).
In adults with persistent asthma, elevated blood eosinophil levels may be able to predict which individuals are at increased risk for exacerbations.

Eosinophils are white blood cells that become active in individuals with certain allergic diseases, including asthma, and other medical conditions such as parasitic infections.

Physicians at Kaiser Permanente (San Diego, CA, USA) measured blood eosinophil level in 2,392 adult asthma patients in 2010 and the relationship between these levels and the rate of exacerbations in 2011 was determined in analyses adjusting for demographics, comorbidities, and asthma burden and care.

The scientists found that increasing level of blood eosinophil at baseline was associated with increasing risk of future asthma exacerbation in both crude and adjusted analyses. The relationship was observed in crude analysis for baseline eosinophil level of greater than 300/mm3 with crude rate ratio 1.25, but was weaker after adjustment for baseline characteristics with an adjusted rate ratio 1.16.

In 2011, after adjustment for baseline features, the adjusted rate ratio of 1.31, which was highly significant, the authors concluded that a baseline eosinophil level of greater than 400/mm3 was associated with future asthma exacerbations. Other factors in 2010 that were significantly associated with an increased risk of exacerbations in 2011 included a history of prior asthma exacerbations, Global Initiative for Asthma (GINA) steps-4/5, dispensing of seven or more short-acting beta-agonist canisters, female gender, black ethnicity, and obesity.

Robert S. Zeiger, MD, PhD, the Physician Investigator at Kaiser Permanente, said, “Eosinophils are known to be involved in the pathophysiology of asthma, and determining their relationship with asthma exacerbations may allow us to determine in advance which of these patients needs targeted interventions. In our study, elevated blood eosinophil levels were found to be a risk factor for subsequent exacerbations in adult asthma patients”.

Dr. Zeiger added “Our findings suggest that asthma patients with an elevated blood eosinophil level have a greater disease burden. If our findings can be replicated in other populations and settings, measurement of blood eosinophil levels may help guide treatment for patients at the greatest risk for exacerbations.” The study was presented at the American Thoracic Society International Conference, held May 16–21, 2014, in San Diego (CA, USA).

Related Links:

Kaiser Permanente




DiagCor Bioscience
ADVANCED INSTRUMENTS
VIRCELL
comments powered by Disqus
Life Technologies

Channels

Genetic Tests

view channel

Next Generation Sequencing Reveals Genetic Basis for Congenital Cataracts

Applying the latest high-throughput, next-generation DNA sequencing technology has enabled researchers in the United Kingdom to diagnose children with rare diseases that are characterized by the formation of congenital cataracts. Diagnosing which of the more than 100 diseases that cause between 20,000 and 40,000 cases... Read more

Immunology

view channel
Image: The fluorescence-activated cell sorting FACSCanto II flow cytometer (Photo courtesy of BD Biosystems).

Flow Cytometry Detects Lymphoproliferative Disorders in Fluid Specimens

Immunophenotypic analysis of hematopoietic cell populations by flow cytometry has emerged as a useful ancillary study in the diagnostic evaluation of serous effusions and cerebrospinal fluids (CSFs).... Read more

Pathology

view channel
Image: Histopathology of increased endomysial connective tissue from a patient with Duchenne Muscular Dystrophy. Necrotic fibers arrowed (Photo courtesy of Washington University in St. Louis).

New Partnership Designed to Automate Dystrophin Measurement

A developer of innovative ribonucleic acid (RNA)-based therapeutics, Sarepta Therapeutics, Inc. ( Cambridge, MA, USA), and a leading tissue-based companion diagnostics firm, Flagship Biosciences LLC (Boulder,... Read more

Lab Tech.

view channel
Image: A technical breakthrough for DNA imaging has been achieved that should quicken diagnosis of diseases for which analysis of DNA from single-cells is critical, such as early stage cancers and various pre-natal conditions (Photo courtesy of McGill University and Génome Québec Innovation Center).

Breakthrough DNA Analysis Technology to Hasten Problem Diagnosis

Researchers have achieved a technical breakthrough that should result in speedier diagnosis of diseases for which analysis of DNA from single-cells is critical, such as early stage cancers and various... Read more

Industry News

view channel

Most IVD Sector Companies Look Outside the EU and USA for Growth

Kalorama Information (New York City, NY, USA) has now published the 9th edition of its biennial market research report “Worldwide Market for In Vitro Diagnostics,” revealing estimates from its survey of the in vitro diagnostics (IVD) industry – presenting the trends, technologies, customer needs, and major suppliers with... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.